Qiagen GmbH FDA Record
- Latest inspection NAI · Mar 12, 2026
- No warning letters matched by name
Qiagen GmbH has 6 FDA recalls, 5 inspections, 18 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Qiagen GmbH" is on file.
- Latest recall
- Z-2665-2023 · Class II · Aug 22, 2023
- Latest inspection
- Mar 12, 2026 · NAI
- Latest 510(k)
- Sep 24, 2026
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 6 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 18 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 5 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Qiagen GmbH: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 4 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 1 | 0 |
| 2017 | 1 | 0 | 0 | 1 | 0 |
Reviewing Qiagen GmbH as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Qiagen GmbH yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-2665-2023 | Class II | therascreen ¿KRAS RGQ PCR Kit (24)-IVD qualitative PCR assay used on the Rotor-Gene Q MDx instrument… | Aug 22, 2023 |
| Z-2245-2023 | Class II | QIAstat-Dx Respiratory SARS-CoV-2 Panel -US IVD qualitative test intended for analyzing… | May 19, 2023 |
| Z-2246-2023 | Class II | QIAstat-Dx Respiratory SARS-CoV-2 Panel (V1 and V2, CE IVD, not US IVD, not sold in the US.)… | May 19, 2023 |
| Z-2215-2023 | Class II | QIAstat-Dx¿ Respiratory SARS-CoV-2 Panel -IVD intended for the detection and differentiation of… | May 9, 2023 |
| Z-2596-2018 | Class II | EZ1 DSP Virus Kit (48), IVD, REF 62724 intended for in vitro diagnostic use. | May 28, 2018 |
| Z-0274-2018 | Class II | QIAamp DSP Virus Kit Cat. No. 60704 | Jul 22, 2017 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Mar 12, 2026 | Hilden, Germany | Devices | No Action Indicated (NAI) | 3004013603 |
| Nov 4, 2022 | Hilden, Germany | Devices | Voluntary Action Indicated (VAI) | 3004013603 |
| Feb 9, 2017 | Hilden, Germany | Devices | No Action Indicated (NAI) | 3004013603 |
| Aug 27, 2015 | Hilden, Germany | Devices | No Action Indicated (NAI) | 3004013603 |
| Sep 26, 2013 | Hilden, Germany | Devices | No Action Indicated (NAI) | 3004013603 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3004013603 | Hilden, Germany | 5 | Mar 12, 2026 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K262168 | QIAstat-Dx BCID GN Plus AMR Panel | Sep 24, 2026 |
| K254194 | QIAstat-Dx BCID GPF Plus AMR Panel | Aug 6, 2026 |
| K254032 | QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B | Mar 9, 2026 |
| K252329 | QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B | Oct 22, 2025 |
| K250080 | QIAstat-Dx Respiratory Panel Plus; QIAstat-Dx Respiratory Panel Mini | Aug 27, 2025 |
| K250324 | QIAstat-Dx GI Panel 2 Mini B | Feb 28, 2025 |
| K243813 | QIAstat-Dx GI Panel 2 Mini B&V | Jan 8, 2025 |
| K242256 | QIAstat-Dx Meningitis/Encephalitis (ME) Panel | Oct 29, 2024 |
| K242353 | QIAstat-Dx Respiratory Panel Mini | Oct 25, 2024 |
| K220062 | QIAstat-Dx Gastrointestinal Panel 2 | May 31, 2024 |
| K233100 | QIAstat-Dx® Respiratory Panel Plus | May 10, 2024 |
| K183597 | QIAstat-Dx Respiratory Panel | May 18, 2019 |
| K172287 | ipsogen JAK2 RGQ PCR Kit | Jan 12, 2018 |
| DEN160028 | ipsogen JAK2 RGQ PCR Kit | Mar 27, 2017 |
| K142738 | artus HSV-1/2 QS-RGQ MDx Kit | Dec 19, 2014 |
| K133936 | ARTUS C. DIFFICILE QS-RGQ MDX KIT | Apr 4, 2014 |
| K113323 | ARTUS INFL A/B RG RT-PCR KIT | Feb 6, 2012 |
| K113319 | ROTOR-GENE Q MDX | Feb 6, 2012 |
Qiagen GmbH and the FDA: common questions
Has Qiagen GmbH received an FDA warning letter?
No FDA warning letter addressed to the name "Qiagen GmbH" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Qiagen GmbH received an FDA Form 483?
FDA has not published a Form 483 for "Qiagen GmbH" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Qiagen GmbH?
The most recent FDA inspection on file ended Mar 12, 2026 at Hilden, Germany and was classified NAI. FDA has 5 inspections of Qiagen GmbH on file.
Has Qiagen GmbH had an FDA recall?
Yes. Qiagen GmbH has 6 FDA recalls on record. The most recent started Aug 22, 2023.
Need more than this page shows? Ask about Qiagen GmbH in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.